Previous researches demonstrated that serum tumor markers such as CEA, CA125, and CA153 were associated with tumor burden indicators including tumor size, node status, and TNM stage.6, 7 In our study, only CA153 shared the similar result. The gene discussed is MUC16; the disease is neoplasm.